Jump Financial, LLC Neogenomics Inc Transaction History

Jump Financial, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 21, 2024	BUY	$12.15 - $17.85 $82,911 - $121,808	6,824 Added 17.58%	45,634 $561,000
Q3 2023 Nov 07, 2023	BUY	$12.15 - $17.85 $82,911 - $121,808	6,824 Added 17.58%	45,634 $561,000
Q2 2023 Oct 21, 2024	BUY	$14.1 - $19.83 $330,546 - $464,874	23,443 Added 152.55%	38,810 $623,000
Q2 2023 Aug 07, 2023	BUY	$14.1 - $19.83 $330,546 - $464,874	23,443 Added 152.55%	38,810 $623,000
Q1 2023 Oct 21, 2024	BUY	$9.09 - $19.45 $139,686 - $298,888	15,367 New	15,367 $267,000
Q1 2023 May 03, 2023	SELL	$9.09 - $19.45 $710,192 - $1.52 Million	-78,129 Reduced 83.56%	15,367 $267,000
Q4 2022 Feb 13, 2023	SELL	$6.45 - $12.07 $139,345 - $260,760	-21,604 Reduced 18.77%	93,496 $863,000
Q3 2022 Nov 07, 2022	SELL	$7.86 - $12.91 $39,300 - $64,550	-5,000 Reduced 4.16%	115,100 $991,000
Q2 2022 Aug 09, 2022	SELL	$7.06 - $13.97 $20,509 - $40,582	-2,905 Reduced 2.36%	120,100 $979,000
Q1 2022 May 12, 2022	BUY	$12.15 - $35.28 $1.25 Million - $3.62 Million	102,743 Added 507.07%	123,005 $1.49 Million
Q4 2021 Feb 10, 2022	BUY	$30.49 - $48.49 $617,788 - $982,504	20,262 New	20,262 $692,000

291

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.82B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.